Neuropathic pain Quality of life G62.9
Conditions
Interventions
Group 1: Qutenza™-plaster, capsaicin, 8%ig, 640µg/cm2, apllication by means of the medical skilled, at maximum four patches/treatment, 30-60 minutes per treatment, frequence depends on the specific co
Sponsors
Zentrum für Schmerztherapie und Palliativmedizin Heidelberg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: The persons who are included in the trial should have 18 years. These should be treated at the university hospital of Heidelberg since 2010 with the Qutenza-plaster for the reason of chronic neuropathic pain.
Exclusion criteria
Exclusion criteria: It doesn´t exist an exclusion criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intensity of the pain bevor and after the treatment with the Qutenza-plaster. A positive effect can be detect when the pain scale (numeric rating scale) is reduced by =3 points. The process data is collected in the files of patients and a questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| -change of quality of pain -quality of life -diagnosis of the pain -number of treatments with the patch -quality of sleep -side effects -non-medicinal therapy (additional) -change of medication -intensity of current pain The survey will be realized with a individually developed questionnaire. This one will be hand over to all patients at the end of October 2016 and includes questions about one to six treatments. | — |
Countries
Germany
Outcome results
None listed